Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 234 | 182 | 112 | 449 | 144 |
| Cost of Goods | 154 | 131 | 99 | 529 | 106 |
| Gross Profit | 80 | 51 | 12 | -80 | 38 |
| Operating Expenses | 1,531 | 1,697 | 1,718 | 2,945 | 1,826 |
| Operating Income | -1,451 | -1,646 | -1,705 | -3,025 | -1,788 |
| Interest Expense | 2 | 3 | 3 | 3 | 3 |
| Other Income | 5 | 25 | 64 | 14 | 4 |
| Pre-tax Income | -1,448 | -1,624 | -1,644 | -3,015 | -1,787 |
| Net Income Continuous | -1,448 | -1,624 | -1,644 | -3,015 | -1,787 |
| Net Income | $-1,448 | $-1,624 | $-1,644 | $-3,015 | $-1,787 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EBITDA(a) | $-1,381 | $-1,558 | $-1,578 | $-2,946 | $-1,719 |